title: Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
abstract: We define delayed graft function (DGF) as the need for dialysis during the first post-transplant week. We analyzed 5272 transplants, of which 2486 were of living donor (LD) and 2786 were of cadaver donor (CD) origin. Twelve per cent (620/5272) of all patients developed DGF. Donor specific rates were 5.6% for LD and 19.1% for CD patients. Factors predictive of DGF in CD patients were: African-American race (25%), prolonged cold ischemia (24%), absence of T-cell induction antibody therapy and absence of HLA-DR matching. The relative risk (RR) for graft failure due to DGF was 6.02 (p < 0.001) in LD patients and 2.58 (p < 0.001) for CD recipients. Two-year graft survival (GS) in LD patients without DGF was 89.6%, compared to 41.6% for those with DGF (p < 0.001); in CD patients it was 80.2% and 49.5%, respectively (p < 0.001). Censoring for primary non-function, GS for LD patients with a functioning graft at 30 d post-transplant and no DGF was 91.5%, compared to 70.1% for those with DGF (p < 0.001); GS for CD patients was 83.8% and 68.7%, respectively (p < 0.001). However, when patients whose grafts had failed during the first year were censored no differences in GS were noted between patients with and without DGF for either LD or CD recipients. To determine whether DGF acts as an independent risk factor for graft failure, patients were segregated into four groups: rejection with DGF; rejection without DGF; DGF without rejection; and no DGF, no rejection. When these groups were compared DGF emerged as an independent risk factor for graft failure. This large study reviewing pediatric renal transplantation over 10 yr clearly delineates the role of DGF as a major risk factor for graft failure.
authors.affiliation: Department of Pediatrics, New York Medical College, Valhalla, USA.
authors.forename: A H
authors.initials: AH
authors.lastname: Tejani
authors.forename: E K
authors.initials: EK
authors.lastname: Sullivan
authors.forename: S R
authors.initials: SR
authors.lastname: Alexander
authors.forename: R N
authors.initials: RN
authors.lastname: Fine
authors.forename: W E
authors.initials: WE
authors.lastname: Harmon
authors.forename: E C
authors.initials: EC
authors.lastname: Kohaut
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006084:Graft Rejection / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D007668:Kidney / Q000502:physiology*; D016030:Kidney Transplantation / Q000502:physiology*; D006435:Renal Dialysis; D012189:Retrospective Studies; D012307:Risk Factors